Sclerosing Solutions [sklerotizující roztoky]

topical
65
Terms

sklerotizační injekce
sklerotizační látky
sklerotizační léky
sklerotizační roztoky
sklerotizující injekce
sklerotizující látky
sklerotizující léky
sklerozanty

 

Injections, Sclerosing
Sclerosant
Sclerosants
Sclerosing Agent
Sclerosing Agents
Sclerosing Drugs
Sclerosing Injection
Sclerosing Injections
Sclerosing Solution

Persistent link   https://www.medvik.cz/link/D012597
Definition

Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE.

Annotation
coordinate /ther use with disease /ther, not disease /drug ther
DUI
D012597 MeSH Browser
CUI
M0019546

Allowable subheadings

AD
administration & dosage 15
AE
adverse effects 7
AN
analysis
CS
chemical synthesis
CH
chemistry 1
CL
classification 1
EC
economics
HI
history
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics
PD
pharmacology 1
PO
poisoning
RE
radiation effects
ST
standards
SD
supply & distribution
TU
therapeutic use 37
TO
toxicity

D Chemicals and Drugs
D26 Pharmaceutical Preparations 7 045
D26.776 Solutions 682
D26.776.708 Pharmaceutical Solutions 195
D26.776.708.160 Cardioplegic Solutions 36
D26.776.708.322 Dialysis Solutions 109
D26.776.708.645 Ophthalmic Solutions 236
D26.776.708.733 Parenteral Nutrition Solutions 36
D26.776.708.822 Sclerosing Solutions 65
D27 Chemical Actions and Uses 374
D27.505 Pharmacologic Actions 409
D27.505.954 Therapeutic Uses 61
D27.505.954.411 Cardiovascular Agents 475
D27.505.954.411.097 Anti-Arrhythmia Agents 1 139
D27.505.954.411.162 Antihypertensive Agents 3 012
D27.505.954.411.192 Calcium Channel Blockers 1 284
D27.505.954.411.207 Cardioplegic Solutions 36
D27.505.954.411.222 Cardiotonic Agents 225
D27.505.954.411.320 Fibrinolytic Agents 523
D27.505.954.411.455 Natriuretic Agents 8
D27.505.954.411.590 Nitric Oxide Donors 63
D27.505.954.411.645 Potassium Channel Blockers 65
D27.505.954.411.700 Sclerosing Solutions 65
D27.505.954.411.720 Sodium Channel Blockers 42
D27.505.954.411.793 Vasoconstrictor Agents 221
D27.505.954.411.918 Vasodilator Agents 800
D27.505.954.578 Pharmaceutical Solutions 195
D27.505.954.578.322 Cardioplegic Solutions 36
D27.505.954.578.483 Dialysis Solutions 109
D27.505.954.578.645 Ophthalmic Solutions 236
D27.505.954.578.733 Parenteral Nutrition Solutions 36
D27.505.954.578.822 Sclerosing Solutions 65
D27.720 Specialty Uses of Chemicals 56
D27.720.752 Pharmaceutical Solutions 195
D27.720.752.322 Cardioplegic Solutions 36
D27.720.752.483 Dialysis Solutions 109
D27.720.752.608 Ophthalmic Solutions 236
D27.720.752.733 Parenteral Nutrition Solutions 36
D27.720.752.822 Sclerosing Solutions 65

Add